Annual Working Capital
$305.12 M
-$88.62 M-22.51%
31 December 2023
Summary:
IGM Biosciences annual working capital is currently $305.12 million, with the most recent change of -$88.62 million (-22.51%) on 31 December 2023. During the last 3 years, it has fallen by -$50.92 million (-14.30%). IGMS annual working capital is now -22.51% below its all-time high of $393.74 million, reached on 31 December 2022.IGMS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$185.67 M
-$42.70 M-18.70%
30 September 2024
Summary:
IGM Biosciences quarterly working capital is currently $185.67 million, with the most recent change of -$42.70 million (-18.70%) on 30 September 2024. Over the past year, it has dropped by -$169.76 million (-47.76%). IGMS quarterly working capital is now -61.80% below its all-time high of $486.02 million, reached on 30 June 2022.IGMS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.5% | -47.8% |
| 3 y3 years | -14.3% | -25.1% |
| 5 y5 years | +4806.4% | -23.2% |
IGMS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.5% | +43.3% | -61.8% | +8.9% |
| 5 y | 5 years | -22.5% | +4806.4% | -61.8% | +8.9% |
| alltime | all time | -22.5% | +4806.4% | -61.8% | +2963.9% |
IGM Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $185.67 M(-18.7%) |
| June 2024 | - | $228.36 M(-13.8%) |
| Mar 2024 | - | $264.82 M(-13.2%) |
| Dec 2023 | $305.12 M(-22.5%) | $305.12 M(-14.2%) |
| Sept 2023 | - | $355.43 M(-0.6%) |
| June 2023 | - | $357.46 M(+4.8%) |
| Mar 2023 | - | $341.12 M(-13.4%) |
| Dec 2022 | $393.74 M(+84.9%) | $393.74 M(-9.6%) |
| Sept 2022 | - | $435.48 M(-10.4%) |
| June 2022 | - | $486.02 M(+185.2%) |
| Mar 2022 | - | $170.44 M(-20.0%) |
| Dec 2021 | $212.97 M | $212.97 M(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $247.96 M(-8.5%) |
| June 2021 | - | $271.10 M(-16.9%) |
| Mar 2021 | - | $326.36 M(-8.3%) |
| Dec 2020 | $356.03 M(+60.2%) | $356.03 M(+107.8%) |
| Sept 2020 | - | $171.37 M(-9.8%) |
| June 2020 | - | $189.99 M(-7.3%) |
| Mar 2020 | - | $204.96 M(-7.8%) |
| Dec 2019 | $222.22 M(-3527.8%) | $222.22 M(-8.1%) |
| Sept 2019 | - | $241.69 M(+212.1%) |
| June 2019 | - | $77.43 M(-1294.4%) |
| Dec 2018 | -$6.48 M(+1919.6%) | -$6.48 M |
| Dec 2017 | -$321.00 K | - |
FAQ
- What is IGM Biosciences annual working capital?
- What is the all time high annual working capital for IGM Biosciences?
- What is IGM Biosciences annual working capital year-on-year change?
- What is IGM Biosciences quarterly working capital?
- What is the all time high quarterly working capital for IGM Biosciences?
- What is IGM Biosciences quarterly working capital year-on-year change?
What is IGM Biosciences annual working capital?
The current annual working capital of IGMS is $305.12 M
What is the all time high annual working capital for IGM Biosciences?
IGM Biosciences all-time high annual working capital is $393.74 M
What is IGM Biosciences annual working capital year-on-year change?
Over the past year, IGMS annual working capital has changed by -$88.62 M (-22.51%)
What is IGM Biosciences quarterly working capital?
The current quarterly working capital of IGMS is $185.67 M
What is the all time high quarterly working capital for IGM Biosciences?
IGM Biosciences all-time high quarterly working capital is $486.02 M
What is IGM Biosciences quarterly working capital year-on-year change?
Over the past year, IGMS quarterly working capital has changed by -$169.76 M (-47.76%)